| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.731 | 42.709 | 45.989 | 70.150 | 81.409 | 84.496 | 83.958 | 88.809 | 89.962 | 100.597 |
| Total Income - EUR | 13.731 | 42.710 | 45.989 | 70.151 | 81.409 | 84.496 | 83.959 | 88.811 | 89.964 | 100.599 |
| Total Expenses - EUR | 12.961 | 40.553 | 47.449 | 46.813 | 46.368 | 37.862 | 32.290 | 32.136 | 31.792 | 41.926 |
| Gross Profit/Loss - EUR | 770 | 2.156 | -1.460 | 23.337 | 35.041 | 46.635 | 51.670 | 56.675 | 58.172 | 58.673 |
| Net Profit/Loss - EUR | 358 | 1.729 | -1.920 | 22.636 | 34.227 | 45.849 | 50.931 | 55.805 | 57.291 | 56.651 |
| Employees | 1 | 3 | 4 | 3 | 3 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Lexmira Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 130 | 129 | 127 | 124 | 122 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 3.641 | 5.196 | 4.256 | 26.977 | 38.844 | 53.019 | 70.216 | 63.737 | 65.318 | 66.307 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.547 | 3.274 | 3.430 | 15.958 | 9.005 | 10.394 | 9.124 | 53.324 | 35.201 | 46.106 |
| Cash | 1.094 | 1.922 | 826 | 11.019 | 29.839 | 42.624 | 61.092 | 10.413 | 30.116 | 20.202 |
| Shareholders Funds | 403 | 1.783 | -168 | 22.471 | 35.190 | 49.036 | 66.960 | 55.853 | 57.340 | 56.699 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.368 | 3.542 | 4.551 | 4.630 | 3.776 | 3.983 | 3.256 | 7.884 | 7.978 | 9.608 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Lexmira Med Srl